Flagship explainer
What drives Immunocore Holdings plc’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$35.5M | FY2025 |
| |
| Income before tax | −$19.1M | FY2025 |
|
| Operating income | −$45.4M | FY2025 |
|
| $400M | FY2025 |
| |
| Ending assets | $1.1B | FY2025 |
|
| Beginning assets | $1.0B | FY2024 |
|
| $381M | FY2025 |
| |
| $361M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001671927-26-000005